Lessons for fragment library design: analysis of output from multiple screening campaigns (Q30864260)

27 June 2017

Lessons for fragment library design: analysis of output from multiple screening campaigns (English)

1 reference

27 June 2017

I-Jen Chen

1

1 reference

PubMed ID

19495994

27 June 2017

Roderick E Hubbard

series ordinal

2

1 reference

PubMed ID

19495994

27 June 2017

language of work or name

1 reference

3 June 2009

1 reference

Journal of Computer - Aided Molecular Design

27 June 2017

1 reference

27 June 2017

23

1 reference

27 June 2017

8

1 reference

27 June 2017

603-620

1 reference

https://scigraph.springernature.com/pub.10.1007/s10822-009-9280-5

27 June 2017

0 references

cites work

Design and characterization of libraries of molecular fragments for use in NMR screening against protein targets.

1 reference

https://api.crossref.org/works/10.1007%2FS10822-009-9280-5

Reoptimization of MDL keys for use in drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-009-9280-5

Analytical shape computation of macromolecules: I. Molecular area and volume through alpha shape.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-009-9280-5

A New Atom-Additive Method for Calculating Partition Coefficients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-009-9280-5

Cheminformatics Analysis of Organic Substituents: Identification of the Most Common Substituents, Calculation of Substituent Properties, and Automatic Identification of Drug-like Bioisosteric Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-009-9280-5

Prediction of Physicochemical Parameters by Atomic Contributions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10822-009-9280-5

Discovery of dibenzo[c,f][2,7]naphthyridines as potent and selective 3-phosphoinositide-dependent kinase-1 inhibitors

21 January 2018

1 reference

12 December 2020

New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine

1 reference

12 December 2020

Predicting protein druggability

1 reference

12 December 2020

Differences between high- and low-affinity complexes of enzymes and nonenzymes

1 reference

12 December 2020

Structural Basis for High-Affinity Peptide Inhibition of Human Pin1

1 reference

12 December 2020

Comprehensive identification of "druggable" protein ligand binding sites.

1 reference

12 December 2020

Identifying and characterizing binding sites and assessing druggability

1 reference

12 December 2020

Design of adenosine kinase inhibitors from the NMR-based screening of fragments

1 reference

12 December 2020

Molecular scaffold-based design and comparison of combinatorial libraries focused on the ATP-binding site of protein kinases

1 reference

12 December 2020

A simple and fuzzy method to align and compare druggable ligand-binding sites.

1 reference

12 December 2020

Identification of hot spots within druggable binding regions by computational solvent mapping of proteins.

1 reference

12 December 2020

Properties of known drugs. 2. Side chains

1 reference

12 December 2020

Automated prediction of ligand-binding sites in proteins

1 reference

12 December 2020

Automatic identification and representation of protein binding sites for molecular docking

1 reference

12 December 2020

LIGSITE: automatic and efficient detection of potential small molecule-binding sites in proteins.

1 reference

12 December 2020

Identification and mapping of small-molecule binding sites in proteins: computational tools for structure-based drug design

1 reference

12 December 2020

Structure-based identification of small molecule binding sites using a free energy model

1 reference

12 December 2020

The PDBbind database: methodologies and updates

1 reference

12 December 2020

The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structures

1 reference

12 December 2020

Ligand binding: functional site location, similarity and docking

1 reference

12 December 2020

Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites.

1 reference

12 December 2020

Theory and applications of NMR-based screening in pharmaceutical research

1 reference

12 December 2020

Structural and functional analysis of the mitotic rotamase Pin1 suggests substrate recognition is phosphorylation dependent

1 reference

12 December 2020

Functionality maps of binding sites: a multiple copy simultaneous search method

1 reference

12 December 2020

Discovery of a potent CDK2 inhibitor with a novel binding mode, using virtual screening and initial, structure-guided lead scoping

1 reference

12 December 2020

Discovery and development of fatty acid amide hydrolase (FAAH) inhibitors

1 reference

12 December 2020

Design of small molecule libraries for NMR screening and other applications in drug discovery

1 reference

12 December 2020

Structure-based design and protein X-ray analysis of a protein kinase inhibitor

1 reference

12 December 2020

Binding MOAD (Mother Of All Databases)

1 reference

12 December 2020

Simple selection criteria for drug-like chemical matter

1 reference

12 December 2020

Discovery of potent, highly selective, and orally bioavailable pyridine carboxamide c-Jun NH2-terminal kinase inhibitors.

1 reference

12 December 2020

Discovering novel ligands for macromolecules using X-ray crystallographic screening

1 reference

12 December 2020

Library design for fragment based screening

1 reference

12 December 2020

The scaffold tree--visualization of the scaffold universe by hierarchical scaffold classification.

1 reference

12 December 2020

New method for fast and accurate binding-site identification and analysis

1 reference

12 December 2020

Quest for the rings. In silico exploration of ring universe to identify novel bioactive heteroaromatic scaffolds

1 reference

12 December 2020

Informatics and modeling challenges in fragment-based drug discovery.

1 reference

12 December 2020

High-throughput siRNA-based functional target validation

1 reference

12 December 2020

The SHAPES strategy: an NMR-based approach for lead generation in drug discovery.

1 reference

12 December 2020

Privileged molecules for protein binding identified from NMR-based screening

1 reference

12 December 2020

On the nature of cavities on protein surfaces: application to the identification of drug-binding sites

1 reference

12 December 2020

SURFNET: a program for visualizing molecular surfaces, cavities, and intermolecular interactions

1 reference

12 December 2020

Structural analysis of the mitotic regulator hPin1 in solution: insights into domain architecture and substrate binding

1 reference

12 December 2020

Application of fragment screening and fragment linking to the discovery of novel thrombin inhibitors.

1 reference

12 December 2020

Fragment-based lead discovery

1 reference

12 December 2020

The properties of known drugs. 1. Molecular frameworks

1 reference

12 December 2020

Property distribution of drug-related chemical databases.

1 reference

12 December 2020

AffinDB: a freely accessible database of affinities for protein-ligand complexes from the PDB

1 reference

12 December 2020

Ligand-protein database: linking protein-ligand complex structures to binding data

1 reference

12 December 2020

Fragment-based screening using X-ray crystallography and NMR spectroscopy

1 reference

12 December 2020

Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water.

1 reference

12 December 2020

Discovering high-affinity ligands for proteins: SAR by NMR

1 reference

12 December 2020

Selection of heterocycles for drug design

1 reference

12 December 2020

Between a rock and a hard place?

1 reference

12 December 2020

Discovery of a potent inhibitor of the antiapoptotic protein Bcl-xL from NMR and parallel synthesis

1 reference

12 December 2020

A decade of fragment-based drug design: strategic advances and lessons learned

1 reference

12 December 2020

1 reference

12 December 2020

The multiple orthogonal tools approach to define molecular causation in the validation of druggable targets

1 reference

12 December 2020

Exploring the chemogenomic knowledge space with annotated chemical libraries

1 reference

12 December 2020

The SeeDs approach: integrating fragments into drug discovery

1 reference

12 December 2020

Fast prediction and visualization of protein binding pockets with PASS.

1 reference

12 December 2020

4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer

1 reference

12 December 2020

Exploring protein-ligand recognition with Binding MOAD

1 reference

12 December 2020

Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors

1 reference

12 December 2020

Structure-based maximal affinity model predicts small-molecule druggability.

1 reference

12 December 2020

Druggability indices for protein targets derived from NMR-based screening data

1 reference

12 December 2020

sc-PDB: an annotated database of druggable binding sites from the Protein Data Bank

1 reference

12 December 2020

The Binding Database: data management and interface design

1 reference

12 December 2020

Recent developments in fragment-based drug discovery

1 reference

12 December 2020

An integrated approach to fragment-based lead generation: philosophy, strategy and case studies from AstraZeneca's drug discovery programmes.

1 reference

12 December 2020

10.1007/S10822-009-9280-5

Identifiers

DOI

1 reference

27 June 2017

journals/jcamd/ChenH09

1 reference

DBLP Dataset 2021-01-02

28 January 2021

1 reference

PubMed ID

19495994